Emerging Pharma

Digital representation of a DNA double helix composed of glowing blue and yellow particles on a dark blue blurred background.

From Clinical Development to Commercial Launch

Launch expertise built for pharmaceutical companies preparing for their first commercial success.

Perigord helps emerging pharmaceutical and biotech companies build distinctive brands, prepare packaging for regulatory submission and launch new therapies into global markets.

‍

We combine brand strategy, creative design, pharmaceutical artwork, labelling, software and marketing services to support the journey from clinical development to commercialisation.

Built for Emerging Pharma Launches

We understand the pressures facing pharmaceutical and biotech companies preparing for their first commercial launch. Our teams help navigate complex requirements, competing priorities and evolving needs as products move towards market.

Making Complex Science Clear, Credible and Compliant

We translate complex scientific information into distinctive brand narratives and clear, engaging communications that connect with healthcare professionals, patients and payers.

Supporting Your First Commercial Launch

Bringing a new therapy to market requires coordinated brand development, regulatory packaging preparation and commercial planning. Perigord brings these capabilities together, helping emerging pharma and biotech companies prepare for launch and scale their operations as products move into global markets.

Pharmaceutical Brand Creation

We develop pharmaceutical brand strategies, identities and scientific narratives that establish distinctive brands and create a foundation for future growth.

Packaging and Submission Readiness

We combine pharmaceutical packaging design, regulatory artwork and labelling expertise to prepare packaging assets for submission and commercial production.

Commercial Launch Preparation

We develop HCP and patient communications, digital experiences and marketing assets to support the introduction of new therapies.

Commercial Launch and Global Execution

Our global teams support packaging artwork production, regulatory updates, market adaptations and ongoing brand communications as products enter new markets.

Supporting Global Launch Infrastructure

Perigord operates exclusively within the life sciences sector.

‍

We combine deep scientific understanding with regulatory expertise, ensuring every deliverable aligns with global standards including FDA, EMA, and MLR requirements. This specialist focus enables us to translate complex science into clear, compliant communications that support successful product launches and sustained commercial growth.

‍

Our quality systems align with GxP and GMP best practices, ensuring compliant content creation and the secure management of sensitive healthcare data across global markets.

Five badges displaying compliance and certification standards: ISO 9001:2015 Certified, GMP/GAMP Compliant, PS 9000:2016 Certified, 21 CFR Part 11 / Annex 11 Compliant, and ISO 27001:2022 Certified.

Meet the Team

Our teams bring extensive experience across the life sciences landscape — from understanding the science behind the therapy to navigating the commercial realities of bringing it to market.

Working closely with medical, regulatory, market access, and commercial stakeholders, we ensure every communication is scientifically credible, strategically aligned, and relevant to the real-world environments where therapies are prescribed, reimbursed, and delivered.

Gary Orr
Chief Commercial Officer
Gabriele Iannizzotto
Chief Business Officer
Nickey Ratcliffe
Global Client Director
Jarek Podoba
Global Creative Director
Lenny Figorski
Head of Consultancy

Starting a new project or want to know more about what we can offer?

Our team is ready to support you at every stage.